Skip to main content
. 2021 Jun 7;12:3400. doi: 10.1038/s41467-021-23620-z

Fig. 6. The performance of plasma NfL concentration cutoffs to identify neurodegenerative disorders in >65 and <65 years.

Fig. 6

The performance of plasma neurofilament light (NfL) concentration cutoffs to identify neurodegenerative disorders in >65 (A) and <65 (B). The KCL and Lund cohorts are combined for this analysis. AD   Alzheimer’s disease, ALS   amyotrophic lateral sclerosis, CBS   corticobasal syndrome, DLB   dementia with Lewy bodies, DS   Down syndrome, DSAD   Down syndrome Alzheimer’s disease, EOAD   early-onset Alzheimer’s disease, FTD   frontotemporal dementia. MCI    mild cognitive impairment, MSA   multiple system atrophy, PD   Parkinson’s disease, PDD   Parkinson’s disease dementia, PSP   progressive supranuclear palsy, SCD   subjective cognitive decline, VaD vascular dementia.